4//SEC Filing
MCCANN JOE A. 4
Accession 0001104659-22-041123
CIK 0001811764other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:56 PM ET
Size
5.4 KB
Accession
0001104659-22-041123
Insider Transaction Report
Form 4
MCCANN JOE A.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-29+381,795→ 381,795 totalExercise: $8.13Exp: 2028-03-29→ Common Stock (381,795 underlying)
Footnotes (1)
- [F1]The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter.
Documents
Issuer
POINT Biopharma Global Inc.
CIK 0001811764
Entity typeother
Related Parties
1- filerCIK 0001868644
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 4:56 PM ET
- Size
- 5.4 KB